English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/87704
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93

AuthorsCostenaro, Luis ; Kaczmarska, Zuzanna ; Arnan, Carme ; Janowski, Robert ; Coutard, Bruno; Solà, Maria ; Gorbalenya, Alexander E.; Norder, Heléne; Canard, Bruno; Coll, Miquel
Issue Date2011
PublisherAmerican Society for Microbiology
CitationJournal of Virology 85(20): 10764-10773 (2011)
AbstractMembers of the Enterovirus genus of the Picornaviridae family are abundant, with common human pathogens that belong to the rhinovirus (HRV) and enterovirus (EV) species, including diverse echo-, coxsackie- and polioviruses. They cause a wide spectrum of clinical manifestations ranging from asymptomatic to severe diseases with neurological and/or cardiac manifestations. Pandemic outbreaks of EVs may be accompanied by meningitis and/or paralysis and can be fatal. However, no effective prophylaxis or antiviral treatment against most EVs is available. The EV RNA genome directs the synthesis of a single polyprotein that is autocatalytically processed into mature proteins at Gln ↓ Gly cleavage sites by the 3C protease (3Cpro), which has narrow, conserved substrate specificity. These cleavages are essential for virus replication, making 3Cpro an excellent target for antivirus drug development. In this study, we report the first determination of the crystal structure of 3Cpro from an enterovirus B, EV-93, a recently identified pathogen, alone and in complex with the anti-HRV molecules compound 1 (AG7404) and rupintrivir (AG7088) at resolutions of 1.9, 1.3, and 1.5 Å, respectively. The EV-93 3Cpro adopts a chymotrypsin-like fold with a canonically configured oxyanion hole and a substrate binding pocket similar to that of rhino-, coxsackie- and poliovirus 3C proteases. We show that compound 1 and rupintrivir are both active against EV-93 in infected cells and inhibit the proteolytic activity of EV-93 3Cpro in vitro. These results provide a framework for further structure-guided optimization of the tested compounds to produce antiviral drugs against a broad range of EV species. © 2011, American Society for Microbiology.
URIhttp://hdl.handle.net/10261/87704
DOI10.1128/JVI.05062-11
Identifiersdoi: 10.1128/JVI.05062-11
issn: 0022-538X
e-issn: 1098-5514
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
Structural basis.pdf5,1 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.